To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Topic Amgen
Companies Amgen
Amgen Inc., USA
Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA an more
News Amgen
-
UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis
UCB and Amgen announced the start of their sclerostin antibody (CDP7851/AMG 785) Phase 3 clinical trial program for the treatment of postmenopausal osteoporosis."We look forward to working with UCB on the CDP7851/AMG 785 Phase 3 program," said Sean E. Harper, M.D., executive vice president of Resear more
-
Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers
The Amgen Foundation and European Schoolnet launched the "Amgen Science Teacher Training Initiative" in France, Germany, Ireland and Poland.The Amgen Science Teacher Training Initiative provides professional development for secondary school science teachers to help them incorporate hands-on enquiry- more
-
Amgen to Acquire Micromet
Amgen and Micromet, Inc.announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany, for $11 per share in cash. The transaction, which values Micromet at approximately $1.16 billion, was unanimously more
White papers Amgen
-
Frost & Sullivan's Global PharmAlliance 2005: Becoming the Partner of Choice
Looking at the increasing trend towards partnerships and alliances in the pharmaceutical industry, Frost & Sullivan a global growth consulting company had organized a premium conference, "Global PharmAlliance 2005 - Becoming the partner of choice" in Mumbai (India). The two day event focused on giving an insight into the world of partnerships and alliances through... more
Publications Amgen
-
Ligand Binding Assays in the 21st Century Laboratory: Automation
Ligand Binding Assays in the 21st Century Laboratory: Automation Content Type Journal Article Category Commentary Pages 1-12 DOI 10.1208/s12248-012-9323-z Authors Ago B. Ahene, XOMA Corporation, 2710 Seventh Street, Berkeley, California 94710, USA Chris Morrow, Genentech, South San Fra more
-
Ligand Binding Assays in the 21st Century Laboratory: Platforms
Ligand Binding Assays in the 21st Century Laboratory: Platforms Content Type Journal Article Category Commentary Pages 1-6 DOI 10.1208/s12248-012-9321-1 Authors Franklin P. Spriggs, Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., 1 Burtt Road, MS G2002, Andover, more
-
Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process
Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process Content Type Journal Article Category Commentary Pages 1-8 DOI 10.1208/s12248-011-9319-0 Authors Sheldon S. Leung, Pfizer Inc., 1 Burtt Rd, Andover, Massachusetts 01810, USA more
Market studies Amgen
-
Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Introduction GlobalData, the industry analysis specialist, has released its new report, “Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Osteopenia Therapeutics market. The report identifies the more
-
Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
Introduction GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020”. The report is an essential source of information and analysis on the global ovarian cancer therapeutics market. The report provi more
-
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
GBI Research, the leading business intelligence provider, has released its latest report, “Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014”. The report is built using data and information sourced from proprietary databas more
Websites Amgen
Trillium Therapeutics Inc. (TTI)
Corporate Overview History Management Team Board of Directors Scientific Advisory Board Current Investors Overview Therapeutic Areas Pipeline Publications Press Releases Presentations Careers Board of Directors Michael Moore, PhD, DSc Chairman Dr. Moore was most recently Chief Executive Officer and more
4-Antibody - Management
A A Home About Us Investors Management Board of Directors Scientific Advisory Board Technologies Antibodies Overview Intellectual Property Glossary Partnering Press Room Career Contact Maps & Directions Basel Site Maps & Directions Jena Site Management Currently employing 40 staff, 4-Antibody’s pote more
Asection
BioCentury c84c72c69c32c66c69c82c78c83c84c69c73c78c32c82c69c80c79c82c84c32c79c78c32c66c73c79c66c85c83c73c78c69c83c83 c32c153 G65G114G116G105G99G108G101G32 G82G101G112G114G105G110G116G32 G149G32 G80G97G103G101G32 G49G32 G111G102G32 G50 G82G69G80G82G73G78G84G32G70G82G79G77G32G70G69G66G82G85G65G82G89G3 more
Watchlist
This is where you can add this topic to your personal favourites
